To address the above issue, we aimed to explore whether the lymphocyte–C-reactive protein ratio (LCR) can differentiate disease severity of COVID-19 patients and its value as an assistant screening tool for hospital and ICU admission. The gene discussed is CRP; the disease is COVID-19.